|
Epigenetic Therapeutic Targets Summit, 7/15/2021: Clinical Development of ZEN-3694 in Solid Tumors
|
8
|
Zenith Epigenetics
|
Jul 22, 2021 09:58AM
|
|
Epigenetic Therapeutic Targets Virtual Summit Presentation July 28, 2020
|
5
|
Zenith Epigenetics
|
Jul 28, 2020 10:05PM
|
|
Epigenetic Therapeutic Targets Virtual Summit Presentation July 28, 2020
|
5
|
Resverlogix Corp.
|
Jul 28, 2020 10:27PM
|
|
Epigenetics in CKD & CVD: A potential breakthrough therapy? Epigenetics in CKD & CVD: A potential breakthrough therapy?
|
4
|
Resverlogix Corp.
|
Mar 31, 2018 11:37AM
|
|
Epigenetics: A closer look at Apabetalone
|
8
|
Resverlogix Corp.
|
Sep 02, 2016 01:30PM
|
|
Epizyme shares slump as cancer drug data update disappoints
|
1
|
Zenith Epigenetics
|
Jun 14, 2017 11:16AM
|
|
ERA-EDTA 2018 Symposium Presentations "Epigenetics in CKD & CVD: A potential breakthrough therapy?"
|
1
|
Resverlogix Corp.
|
Dec 14, 2018 01:32PM
|
|
ERA-EDTA 2019 June 13-16
|
3
|
Resverlogix Corp.
|
Jun 11, 2019 07:28PM
|
|
ERA-EDTA 2019 Symposium: Vascular calcification in kidney disease: Epigenetics as a novel approach?
|
4
|
Resverlogix Corp.
|
Apr 14, 2019 09:23AM
|
|
ESC 2016 Symposium
|
6
|
Resverlogix Corp.
|
Jun 15, 2016 12:52PM
|
|
ESC 2017
|
3
|
Resverlogix Corp.
|
Jun 09, 2017 11:18AM
|
|
ESC 2017 Abstracts are up
|
9
|
Resverlogix Corp.
|
Aug 24, 2017 10:25AM
|
|
ESC 2018 Symposium
|
5
|
Resverlogix Corp.
|
Jun 19, 2018 03:11PM
|
|
ESC 2018 Symposium and Presentation August 25-29, Munich
|
7
|
Resverlogix Corp.
|
Aug 14, 2018 01:55PM
|
|
ESC 2019 Symposium: Epigenetics: A new pathway to tackle residual risk?
|
7
|
Resverlogix Corp.
|
Jul 05, 2019 04:20PM
|
|
ESC 2020 presentation on BETonMACE
|
14
|
Resverlogix Corp.
|
Aug 26, 2020 11:52AM
|
|
ESC 2021 August 27-30
|
12
|
Resverlogix Corp.
|
Aug 02, 2021 05:41PM
|
|
ESC Poster on BETonMACE Design and Baseline Data
|
3
|
Resverlogix Corp.
|
Sep 02, 2019 08:37AM
|
|
ESC Poster on Vascular Inflammation, Calcification and Plaque Vulnerability
|
4
|
Resverlogix Corp.
|
Sep 03, 2019 09:48AM
|
|
European Atherosclerosis Society 2019 meeting May 26-29
|
7
|
Resverlogix Corp.
|
May 20, 2019 12:18PM
|
